10967/261 - QDB Compounds

QsarDB Repository

Zukić, S.; Osmanović, A.; Harej, A.; Kraljević Pavelić, S.; Špirtović-Halilović, S.; Veljović, E.; Roca, S.; Trifunović, S.; Završnik, D.; Maran, U. Data driven modelling of substituted pyrimidine and uracil-based derivatives validated with newly synthesized and antiproliferative evaluated compounds. Int. J. Mol. Sci. 2024, 25, 9390

Compound

ID:V23
Name:CHEMBL388690
Description:
Labels:Test
CAS:
InChi Code:InChI=1S/C31H26N2O6/c1-2-3-4-5-12-17-25-20-33(31(36)32-29(25)34)19-18-26-27(37-21-23-13-8-6-9-14-23)28(30(35)39-26)38-22-24-15-10-7-11-16-24/h1,6-11,13-16,18,20H,3-5,19,21-22H2,(H,32,34,36)/b26-18-

Properties

pIC50: Antiproliferative activity [-log(uM)] i

ValueSource or prediction
4.42

Gazivoda, T.; Šokčević, M.; Kralj, M.; Šuman, L.; Pavelić, K.; De Clercq, E.; Andrei, G.; Snoeck, R.; Balzarini, J.; Mintas, M.; Raić-Malić, S. Synthesis and Antiviral and Cytostatic Evaluations of the New C-5 Substituted Pyrimidine and Furo[2,3-d]pyrimidine 4‘,5‘-Didehydro-L-ascorbic Acid Derivatives. Journal of Medicinal Chemistry 2007, 50, 4105–4112. http://dx.doi.org/10.1021/jm070324z

4.9038

Eq.1: QSAR model for for antiproliferative activity for HeLa cells (Test set)